He L, Peng L, Zhang H. Comment on "Impact of MRI risk assessment on the survival benefits of neoadjuvant chemoradiotherapy in patients with stage II-III rectal cancer: A retrospective cohort study". Eur J Radiol 2025;192:112364.
PMID: 40839920